Trial intelligence / Profile preview

Prophylactic clofibrate in very low birth weight neonates with hyperbilirubinemia risk

IRCT138706311162N5Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clofibride in neonatal hyperbilirubinemia, sponsored by Mashhad University of Medical Sciences. Started Apr 2006; status: completed.

02

Drugs

clofibride
03

Conditions

neonatal hyperbilirubinemia

Beyond the preview

Go deeper on IRCT138706311162N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138706311162N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call